AtriCure, Inc. - Laporan Laba Rugi (TTM)

AtriCure, Inc.
US ˙ NasdaqGM ˙ US04963C2098

Laporan Laba Rugi (TTM)

Laporan Laba Rugi AtriCure, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 210 207 213 243 259 274 290 303 316 330 349 366 381 399 415 430 448 465 480 500
Change (%) -1.71 2.93 14.37 6.46 5.99 5.58 4.54 4.22 4.69 5.73 4.69 4.11 4.86 3.85 3.70 4.10 3.96 3.17 4.14
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 58 57 58 62 66 68 73 76 80 84 89 92 95 99 103 108 113 118 121 126
Change (%) -2.15 0.69 7.16 6.17 4.45 6.20 5.10 4.32 5.91 5.81 3.17 3.13 4.01 3.74 5.44 4.34 4.37 2.89 4.32
% of Revenue 27.83 27.71 27.10 25.40 25.33 24.96 25.11 25.24 25.26 25.56 25.58 25.21 24.97 24.77 24.74 25.16 25.21 25.31 25.24 25.29
Gross Operating Profit 152 149 155 181 193 206 217 226 236 246 260 274 286 300 312 322 335 348 359 374
Change (%) -1.54 3.79 17.05 6.56 6.51 5.37 4.35 4.19 4.28 5.70 5.22 4.44 5.15 3.88 3.13 4.02 3.83 3.27 4.08
% of Revenue 72.17 72.29 72.90 74.60 74.67 75.04 74.89 74.76 74.74 74.44 74.42 74.79 75.03 75.23 75.26 74.84 74.79 74.69 74.76 74.71
SG&A 147 151 151 174 190 205 214 221 229 231 235 241 245 258 270 275 287 291 295 300
Change (%) 2.42 0.28 15.02 8.94 7.99 4.60 3.40 3.68 0.78 1.71 2.49 1.78 4.97 4.77 1.98 4.25 1.57 1.27 1.62
% of Revenue 70.08 73.03 71.15 71.55 73.22 74.60 73.91 73.10 72.72 70.00 67.34 65.93 64.45 64.51 65.08 64.00 64.09 62.62 61.46 59.98
R&D 45 43 43 45 46 49 51 54 57 57 59 62 67 74 78 81 82 96 99 108
Change (%) -4.91 -0.86 5.06 1.58 6.45 4.97 5.09 7.26 -0.10 2.96 4.48 8.41 10.54 6.11 3.80 0.74 17.27 2.79 8.97
% of Revenue 21.56 20.85 20.09 18.45 17.61 17.68 17.58 17.67 18.19 17.35 16.90 16.87 17.56 18.51 18.92 18.93 18.32 20.67 20.59 21.55
OpEx 251 251 252 281 301 322 338 351 367 373 384 395 407 430 451 465 482 505 515 534
Change (%) 0.03 0.17 11.53 7.16 6.98 5.00 4.02 4.37 1.76 2.83 2.96 3.13 5.66 4.76 3.09 3.66 4.90 1.94 3.67
% of Revenue 119.47 121.59 118.34 115.39 116.15 117.24 116.59 116.01 116.17 112.92 109.82 108.00 106.98 107.79 108.74 108.09 107.63 108.60 107.30 106.82
Operating Income -41 -45 -39 -37 -42 -47 -48 -48 -51 -43 -34 -29 -27 -31 -36 -35 -34 -40 -35 -34
Change (%) 8.98 -12.58 -3.98 11.68 13.15 1.62 0.88 5.26 -16.39 -19.61 -14.72 -9.19 17.06 16.51 -3.98 -1.81 17.14 -12.40 -2.78
% of Revenue -19.47 -21.59 -18.34 -15.39 -16.15 -17.24 -16.59 -16.01 -16.17 -12.92 -9.82 -8.00 -6.98 -7.79 -8.74 -8.09 -7.63 -8.60 -7.30 -6.82
Interest Expense -5 -5 -5 -5 -5 -5 -5 -5 -5 -5 -6 -6 -7 -7 -7 -7 -7 -6 -6 -6
Change (%) -1.27 -0.80 -0.70 4.51 -2.21 -3.84 -2.03 -2.70 10.60 12.76 10.99 7.18 3.54 0.59 -1.54 -1.53 -5.14 -4.07 -1.99
% of Revenue -2.35 -2.37 -2.28 -1.98 -1.94 -1.79 -1.63 -1.53 -1.43 -1.51 -1.61 -1.71 -1.76 -1.73 -1.68 -1.60 -1.51 -1.38 -1.28 -1.20
Net Income -46 -48 -49 -57 45 50 52 53 -56 -46 -38 -28 -25 -30 -37 -40 -39 -45 -38 -36
Change (%) 5.40 1.06 16.47 -180.06 10.62 3.45 2.72 -205.05 -17.08 -18.74 -25.75 -11.47 22.64 22.32 7.76 -3.00 14.85 -14.59 -4.76
% of Revenue -21.74 -23.32 -22.89 -23.31 17.53 18.30 17.93 17.62 -17.76 -14.06 -10.81 -7.67 -6.52 -7.62 -8.98 -9.33 -8.70 -9.61 -7.95 -7.27

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista